David Alan Campbell

Insider Reports History

Entity
Individual
Location
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Alan Campbell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. President and CEO, Director Common Stock 282K $15.2M $53.94 Oct 28, 2024 Direct
Janux Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 357K Jan 2, 2024 Direct

Insider Reports Filed by David Alan Campbell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Oct 28, 2024 2 -$1.34M 4 Oct 30, 2024 President and CEO, Director
JANX Janux Therapeutics, Inc. Sep 27, 2024 3 -$1.16M 4 Sep 27, 2024 President and CEO, Director
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 President and CEO, Director
JANX Janux Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Executive Officer, Director
JANX Janux Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Executive Officer, Director
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Chief Executive Officer, Director